Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children

Gordon Y C Cheung1, Michael Otto

  • 1Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

Insights

Staphylococcus epidermidis and coagulase-negative staphylococci (CoNS) sepsis remain a significant challenge in neonates. Understanding pathogenesis and improving hospital hygiene are crucial for preventing these difficult-to-treat biofilm-associated infections.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Staphylococcus epidermidis and coagulase-negative staphylococci (CoNS) are leading causes of healthcare-associated infections.
  • Neonatal sepsis due to these pathogens presents significant challenges in prevention and treatment.
  • Biofilm formation on indwelling medical devices contributes to persistent and recurrent infections.

Purpose of the Study:

  • To provide an overview of Staphylococcus epidermidis bacteremia/sepsis and CoNS infections in neonates and children.
  • To review recent advancements in understanding the pathogenesis and host interactions of S. epidermidis.
  • To discuss challenges and potential strategies for managing these infections.

Main Methods:

  • Literature review of recent studies on S. epidermidis and CoNS infections.
  • Analysis of pathogenesis, host defense interactions, and risk factors.
  • Evaluation of biofilm formation and antibiotic resistance mechanisms.

Main Results:

  • S. epidermidis and CoNS sepsis incidence remains high in neonates, with difficult treatment outcomes.
  • Progress has been made in understanding S. epidermidis pathogenesis, host interactions, and risk factors.
  • Biofilm-associated catheter infections are a major cause of recurrent CoNS infections in premature neonates, exhibiting intrinsic antibiotic resistance.

Conclusions:

  • S. epidermidis bloodstream infections are particularly problematic in neonates, often linked to biofilm-associated catheter infections.
  • The role of S. epidermidis colonization as potentially beneficial warrants further investigation for prophylactic strategies.
  • Enhanced hospital hygiene is paramount to reduce pathogen introduction on medical devices, alongside developing new therapies targeting virulence and risk factors.
Abstract

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...